Editors Choice

A Digital Turning Point in Migraine Care: CT-132 FDA Approval to Market is a Win for Patients and Proof that Clinical Evidence Matters

First Digital Health App United States Approval for Migraine Treatment with a Comprehensive Indication of Use

2 days ago

Spotlighting Emerging Dementia in Its Many Iterations and Stages

Dementia’s devastation may slip under our notice unless we recognize its many manifestations in behavior, speech, and mood.

2 days ago

Saturday Night Live’s Kenan Thompson’s Health Wake-Up Call

As a physician, I spend much of my day helping people navigate serious illnesses. But even outside of cancer, some…

2 days ago

Empathy and Health Excellence — The Superpower of Care Delivery

When Medicine Transcends the Sterile Clinical Encounter

2 weeks ago

Europe Reimagines Foreign Aid as Investment

As the U.S. slashes foreign aid, Europe rewires its model — less charity, more strategic investment.

2 weeks ago

Am I Swallowing Microplastics Every Time I Chew Gum?

Researchers discovered that a single piece of gum can release 637 microplastic articles per gram

2 weeks ago

Tariffs Can Upset the World of Healthcare and Medications

Medications subject to tariff could mean a return to readily available cultural, homeopathic medications.

2 weeks ago

Consumer HealthTech: A Data-Driven Evolution in Health Engagement

Despite Record Funding, Clinical Validation Gap Threatens Long-Term Growth of Consumer HealthTech Market

2 weeks ago

A Turning Point for Global Health

It’s time to speak with a shared voice in defense of our health security

2 weeks ago

Envisioning a Future with Reversal of Glaucoma-Related Vision Loss

More than 4.2 million Americans live with glaucoma, or about 1.6% of the country’s adult population, and only half are…

3 weeks ago

This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.

Read More